ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207 | -83.8% | 18,546 | -68.9% | 0.00% | -80.0% |
| Q2 2023 | $1,276 | -25.6% | 59,635 | +40.6% | 0.01% | -50.0% |
| Q1 2023 | $1,715 | +91.6% | 42,413 | +120.4% | 0.02% | +81.8% |
| Q4 2022 | $895 | -99.8% | 19,248 | +128.2% | 0.01% | +120.0% |
| Q3 2022 | $437,000 | -62.8% | 8,433 | -66.1% | 0.01% | -61.5% |
| Q2 2022 | $1,176,000 | -38.8% | 24,868 | -8.0% | 0.01% | -7.1% |
| Q1 2022 | $1,923,000 | +798.6% | 27,021 | +842.2% | 0.01% | +1300.0% |
| Q4 2021 | $214,000 | -92.9% | 2,868 | -94.6% | 0.00% | -92.9% |
| Q3 2021 | $3,011,000 | +49.4% | 52,999 | +15.8% | 0.01% | +55.6% |
| Q2 2021 | $2,015,000 | -16.5% | 45,774 | -6.4% | 0.01% | -30.8% |
| Q1 2021 | $2,413,000 | +25.5% | 48,926 | +7.1% | 0.01% | +30.0% |
| Q4 2020 | $1,922,000 | +16.1% | 45,663 | +26.2% | 0.01% | -9.1% |
| Q3 2020 | $1,656,000 | +152.4% | 36,172 | +177.0% | 0.01% | +120.0% |
| Q2 2020 | $656,000 | +191.6% | 13,059 | +197.9% | 0.01% | +150.0% |
| Q1 2020 | $225,000 | -43.9% | 4,384 | -32.5% | 0.00% | -50.0% |
| Q4 2019 | $401,000 | -60.8% | 6,497 | -61.8% | 0.00% | -50.0% |
| Q3 2019 | $1,023,000 | +813.4% | 17,026 | +1181.1% | 0.01% | +700.0% |
| Q2 2019 | $112,000 | -40.1% | 1,329 | -32.0% | 0.00% | -50.0% |
| Q1 2019 | $187,000 | -61.8% | 1,953 | -71.7% | 0.00% | -50.0% |
| Q4 2018 | $489,000 | +135.1% | 6,909 | +284.9% | 0.00% | +100.0% |
| Q2 2018 | $208,000 | +85.7% | 1,795 | +29.1% | 0.00% | +100.0% |
| Q1 2018 | $112,000 | -57.7% | 1,390 | -75.5% | 0.00% | -50.0% |
| Q3 2017 | $265,000 | +68.8% | 5,662 | +30.0% | 0.00% | +100.0% |
| Q2 2017 | $157,000 | +23.6% | 4,354 | +5.8% | 0.00% | 0.0% |
| Q1 2017 | $127,000 | -52.4% | 4,117 | -48.3% | 0.00% | -50.0% |
| Q4 2016 | $267,000 | +159.2% | 7,958 | +135.5% | 0.00% | +100.0% |
| Q1 2015 | $103,000 | -7.2% | 3,379 | +54.7% | 0.00% | 0.0% |
| Q4 2014 | $111,000 | – | 2,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |